Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
Condition: Hepatic Impairment Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
Condition: Health Volunteers Interventions: Drug: Midazolam; Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
Condition: Health Volunteers Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
Condition: Hepatic Impairment Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
Condition: Health Volunteers Interventions: Drug: Midazolam; Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
Condition: Health Volunteers Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
Condition: Hepatic Impairment Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
Condition: Health Volunteers Interventions: Drug: Midazolam; Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
Condition: Health Volunteers Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
Condition: Hepatic Impairment Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
Condition: Health Volunteers Interventions: Drug: Midazolam; Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
Condition: Health Volunteers Intervention: Drug: CTP-543 Sponsor: Concert Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials